1.1. Read these instructions carefully before use. 1.2. Rx ONLY. 1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion. 1.4. For the collection of 500 mL ±10% Whole Blood. 1.5. Integral Diversion Blood Sampling Arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood uni...
2.1. To open blister package, peel cover film back 4/5 of its length. 2.2. Prepare the blood bag following your institution's standard operating procedures. 2.2.1. Materials Needed: VENOJECT®@Tube Holder (code P-1316R) or equivalent VENOJECT@Multi-Sample Luer Adapter (code MN＊2000T) or equivalent Evacuated blood collection tubes (glass or plastic) 2.3. Make a loose knot in the donor tubing below the "Y" and CLIKTI...
16.1. Single use only. 16.2. Sterile and non-pyrogenic fluid path. Sterilized by steam. Opacity of the blood bag system may be observed. This is due to moisture absorption during the sterilization process. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. 16.3. A Material Safety Data Sheet (MSDS) is not required for this product. 16.4. Recommended storage condi...
Revised 2015-12 N-WR-OP-A-DB 2
CPD/OPTISOL® SOLUTION
For the collection of 500 mL of Whole Blood
FULL PRESCRIBING INFORMATION
*Sections or subsections omitted from the Full Prescribing Information are not listed [includes sections 4, 6, 7, 8, 9, 10, 12, 13, 14, 15 and 17].
1.1. Read these instructions carefully before use.
1.2. Rx ONLY.
1.3. Intended for the collection, processing and preservation of Whole Blood and blood components. Not intended for direct intravenous infusion.
1.4. For the collection of 500 mL ±10% Whole Blood.
1.5. Integral Diversion Blood Sampling Arm is intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit.
1.6. Integral filter unit intended for leukocyte reduction of Whole Blood up to 8 hours after blood collection when Whole Blood is stored at ambient temperature or cooled towards 1-10°C (transport temperature).
1.7. For further processing, use standard component processing techniques.
2.1. To open blister package, peel cover film back 4/5 of its length.
2.2. Prepare the blood bag following your institution's standard operating procedures.
2.2.1. Materials Needed:
2.3. Make a loose knot in the donor tubing below the "Y" and CLIKTIP® (inline closure device) unless alternate methods are used to seal the tubing at the end of collection.
2.4. Temporarily clamp donor tubing between the phlebotomy needle and the "Y".
2.5. Close the White Clamp below the diversion pouch.
2.6. Assemble the luer adapter and the tube holder.
2.6.1. Connect the VENOJECT@Multi-Sample Luer Adapter to the VENOJECT@Tube Holder (or equivalent) (Fig. 1).
2.6.2. Twist and snap to remove the blue port cap at the end of the Diversion Blood Sampling Arm (Fig. 2a).
2.6.3. Insert the Holder/Luer assembly in the female luer port (Fig. 2b).
2.6.4. NOTE: Alternatively, steps 2.6.1., 2.6.2., and 2.6.3. (above) may be performed at any time during bag preparation or after the blood is collected into the diversion pouch.
2.7. Suspend the collection bag as far as possible below the donor's arm.
2.8. Apply blood pressure cuff or tourniquet to donor's arm. Disinfect site of phlebotomy. If blood pressure cuff is used, inflate to approximately 60 mmHg.
2.9. Remove the needle cover and perform phlebotomy. Remove the temporary clamp on the donor tubing to permit blood flow into the Diversion Blood Sampling Arm pouch.
2.9.1. CAUTION: Do not touch the needle after removing the needle cover.
2.9.2. CAUTION: Assure that the White Clamp below the pouch is closed prior to initiating phlebotomy.
2.10. Secure the needle safety device in place following the device instructions provided on the reverse side.
2.11. Secure donor tubing to donor's arm.
2.12. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly (or port cap) down. When the level of blood in the pouch is approximately in line with the notches, the diversion pouch is full (Fig. 3a).
2.12.1. NOTE: The approximate fill volume of the pouch at the notches is 35 mL.
2.13. Permanently seal the tubing between the "Y" and the diversion pouch to maintain a closed system using an aluminum clip or a tube sealer approved for use with tubing connected to a donor (Fig. 3b).
2.13.1. CAUTION: Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose.
2.14. To initiate blood flow into the collection bag, break the CLIKTIP between the "Y" and the collection bag.
2.15. To avoid clot formation, collect samples as soon as possible from the diversion pouch as follows (Fig. 3b).
2.15.1. CAUTION: Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed.
2.15.2. Open the White Clamp on the tubing below the pouch to open the pathway for sampling.
2.15.3. Position the diversion pouch with the notches up and the Tube Holder/Luer Adapter assembly downward. Assure that any air in the pouch is at the top and will not enter the blood collection tubes.
2.15.4. Insert blood collection tube firmly into the tube holder; when full, remove sample tube from holder. Repeat to collect additional samples.
2.15.5. NOTE: The pouch may be removed after the donor test samples are collected.
A second seal must be made between the diversion pouch and the permanent seal prior to removing the pouch.
2.16. Mix blood with anticoagulant in the collection bag and continue to mix at several intervals during collection and immediately after collection. If using an automated mixer, follow manufacturer's instructions.
2.17. Collect labeled volume of blood 500 mL ±10%.
2.18. When the desired amount of blood has been collected, seal the tubing or tighten the loose knot (white knot) prepared in Step 2.3. Make a second seal between the first seal or knot and the "Y". Various methods may be used to seal tubing.
2.19. Release pressure on the donor's arm and remove the needle into the needle safety device following the device instructions provided on the reverse side. Sever the donor tubing between the two seals previously made below the CLIKTIP and "Y".
2.19.1. CAUTION: Discard the Diversion Blood Sampling Arm and phlebotomy needle/donor tubing according to institutional standard operating procedures.
2.20. Seal and remove donor tubing from collection bag or strip donor tubing as follows:
2.20.1. To obtain a quality control prefiltration sample, strip blood from donor tubing into collection bag, mix well, and allow tubing to refill; repeat once. To prevent the blood from clotting in the tubing, work quickly as possible. Leave an adequate length of tubing containing the well-mixed anticoagulated whole blood attached to the collection bag.
2.20.2. Or, to maximize collection recovery, strip the tubing, mix well and seal tubing close to the collection bag without refilling. To prevent the blood from clotting in the tubing, work quickly as possible. Remove tubing from collection bag.
2.21. The blood filtration is executed according to the following operation. (see Fig.4)
2.21.1. NOTE: Red blood cells collected from certain donors may have extended filtration times and the potential for ineffective filtration and leukoreduction.
2.21.2. NOTE: Wait 30 minutes after collection before filtering. Filtration can be accomplished at room temperature for units maintained at room temperature and filtered within 8 hours of collection. Filtration can also be performed with units cooled towards 1-10°C within 8 hours of collection (e.g., during transport). If any unit has not completely filtered by 8 hours post collection, filtration must be completed at 1-6°C. Filtration can be unattended.
2.22. Mix the unfiltered whole blood unit by inverting the collection bag #1 (pre-filter bag) several times.
2.23. Hang the collection bag #1 and extend the filtration set to full length. Verify that the filter is vertical and ensure all tubing is freely suspended without kinks.
2.24. Break the CLIKTIP at the outlet of the collection bag #1.
2.24.1. The filter housing will begin to fill with blood and expand on the non-textured side.
2.24.2. Blood will flow across the filter pads and expand the textured side of the filter housing.
2.24.3. Air from the bag and filter will be forced into the primary bag #2 (post-filtration bag).
2.24.3.1. CAUTION: Do not squeeze or apply pressure on the filter while it is attached to the bag containing the filtered blood.
2.25. Filtration ends when the filter has emptied and the housing has collapsed onto the filter pads.
2.25.1. NOTE: Verify that collection bag #1 and pre-filtration tubing has emptied.
2.26. Gently squeeze the primary bag #2 to expel the air in the bag up the numbered segment tubing line and into the filter. To ensure ease of air removal ensure primary bag #2 is below the filter outlet.
2.27. Fill the numbered segment tubing with blood while expelling the air.
2.28. Clamp the blood filled tubing before blood enters the filter.
2.29. Seal the tubing as close as possible to the filter outlet and properly dispose of the filter and collection bag #1.
2.30. Strip the post filter tubing into the primary bag #2, mix well, and allow tubing to refill; repeat once. Make an appropriate number of segments of anticoagulated blood for testing by sealing on or near the X marks. Leave segments attached to the filtered whole blood unit.
2.31. The time between Whole Blood collection and component separation may vary depending on both the blood bag system and processing options selected.
2.31.1. NOTE: Production of Platelet concentrates is not intended with this product.
2.31.2. NOTE: Fresh Frozen Plasma should be separated from the Red Blood Cells and placed in a freezer at –18°C or colder within 8 hours of collection.
2.31.3. NOTE: OPTISOL should be added to the Red Blood Cells immediately after removal of the plasma. If plasma is not separated from the Red Blood Cells within 8 hours, OPTISOL may be added within 72 hours of collection if Whole Blood is refrigerated.
2.32. Follow your institution's standard component processing procedures to prepare components.
2.33. Centrifuge filtered whole blood unit to separate red cells from plasma.
2.34. Break the CLIKTIP of primary bag #2 and transfer leukocytes-reduced plasma into satellite bag #3. Clamp transfer tubing of satellite bag.
2.35. Break the CLIKTIP of OPTISOL Solution bag #4 and drain contents into primary bag #2 containing red blood cells. Seal tubing of primary bag in two places, and cut between seals and separate from satellite bag(s).
2.35.1. NOTE: Empty OPTISOL container may be used for further component preparation.
2.36. Invert the red blood cell – OPTISOL mixture several times to assure the final product is well suspended.
2.37. Store AS-5 Red Blood Cells, Leukocytes Reduced between 1-6°C for up to 42 days.
2.37.1. NOTE: Whole Blood or Red Blood Cells in CPD may be stored for up to 21 days at 1-6°C.
3.1. 70 mL Citrate Phosphate Dextrose (CPD) anticoagulant USP for collection of 500 mL Whole Blood. Each 70 mL contains 1.79 g Dextrose (monohydrate) USP, 1.84 g Sodium Citrate (dihydrate) USP, 209 mg Citric Acid (anhydrous) USP, 156 mg Monobasic Sodium Phosphate (monohydrate) USP.
3.2. 111 mL OPTISOL Red Cell Preservative Solution. Each 111 mL contains 974 mg Sodium Chloride USP, 1.00g Dextrose (monohydrate) USP, 583 mg Mannitol USP, 33.3 mg Adenine USP.
5.1. Rx ONLY.
5.2. Do not use unless solutions are clear and free from particulates.
5.3. Always inspect the blood bag set for leaks before use.
5.4. Avoid excessive heat and direct sunlight. Protect from freezing.
5.5. Recommended storage conditions: Room Temperature (15-30°C/59-86°F).
5.6. It is normal to have condensation in the blister packaging. If the amount of moisture is greater than expected, check for leaks from the fluid-filled components of the blood bag set.
5.7. Use aseptic techniques.
5.8. Do not use a dielectric tube sealer to seal the tubing while the needle is connected to the donor's body unless it is approved for such a purpose.
5.9. Do not touch needle after removing the needle cover.
5.10. Assure that the White Clamp below the pouch is closed prior to initiating phlebotomy.
5.11. Do not collect donor test samples until the tubing between the "Y" and the diversion pouch is permanently sealed.
5.12. Discard the Diversion Blood Sampling Arm and phlebotomy needle/donor tubing according to institutional standard operating procedures.
5.13. The AGELESS® oxygen absorber packet, (Mitsubishi Gas Chemical) contained in this package absorbs oxygen and generates heat on removal. Do not open and handle it with care.
5.14. Dispose of the AGELESS packet with the blister tray.
5.15. Do not dispose the AGELESS packet with wastes containing volatile or flammable materials.
5.16. Due to possible exposure to infectious agents in the handling of blood, take adequate precautions at all times to prevent exposure to and transmission of such agents. Follow your institution's standard operating procedures.
11.1. This blood bag system includes a 16 gauge × 1 1/2 inch (1.60 × 38 mm) needle with needle cover and a 500mL (nominal capacity 600mL) collection bag containing 70mL Citrate Phosphate Dextrose (CPD) anticoagulant. The Quadruple blood bag set has one integrally attached empty primary bag, one empty satellite bag, and one satellite bag containing 111 mL OPTISOL Red Cell Preservative Solution.
11.2. Blood bag codes ending in A2 are the collection set with an Integral Diversion Blood Sampling Arm for obtaining donor samples prior to collection of the Whole Blood Unit. 11.3. Blood bag codes ending in A2 also include a DonorCare® Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side.
11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer).
11.5. The blood bag has no components made of natural rubber latex.
11.6. Tubing internal diameter (ID) nominal 3.0 mm.
11.7. Tubing outer diameter (OD) nominal 4.4 mm.
11.8. Tubing line maximum 16 segments available.
16.1. Single use only.
16.2. Sterile and non-pyrogenic fluid path. Sterilized by steam. Opacity of the blood bag system may be observed. This is due to moisture absorption during the sterilization process. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually.
16.3. A Material Safety Data Sheet (MSDS) is not required for this product.
16.4. Recommended storage conditions: Room Temperature (15-30°C/59-86°F).
16.5. Avoid excessive heat and direct sunlight. Protect from freezing.
16.6. To open blister package, peel cover film back 4/5 of its length.
16.7. After opening the blister package, unused blood bags may be stored at room temperature for 96 hours or they may be stored for 30 days by returning cover film to original position and sealing with tape to prevent evaporation of solutions.
16.8. Blood bags in the unopened blister package may be used through the last day of the month and year as indicated on the original manufacturer's packaging.
16.9. The AGELESS packet contained in this package absorbs oxygen and generates heat on removal. Do not open and handle it with care.
16.10. Dispose of the AGELESS packet with the blister tray.
16.11. Do not dispose the AGELESS packet with wastes containing volatile or flammable materials.
16.12. For the Quadruple blood bag set, Code BB＊WGQ506A2 is supplied 18/case.
MANUFACTURED BY:
TERUMO CORPORATION
44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU,
TOKYO 151-0072, JAPAN MADE IN JAPAN
(R): Registered Trademark ©TERUMO CORPORATION December, 2015
DonorCare is a registered trademark of Noble House Group Pty. Ltd. CORPORATION.
AGELESS is a registered trademark of MITSUBISHI GAS CHEMICAL CO., INC.
This device is for use by trained individuals.
Intended Use
The DonorCare® Needle Guard is incorporated onto the donor tubing to shield the needle immediately after withdrawal from the donor.
Single Use Only.
Preparation
Whole Blood Collection
Withdrawal of Needle
Important
The DonorCare must be held stationary while the needle is withdrawn into it.
Caution
The needle must be fully shielded by DonorCare to prevent accidental injury.
Note: A hemostat may be placed on the tubing behind the DonorCare when the blood collection is complete.
This will help to prevent blood drops from forming.
Warning
Do not place fingers at the opening of DonorCare after removal from the donor's arm.
Difficult Phlebotomy (Examples may include: Slow blood flow, deep or fine vein, steep angle)
It may be necessary to delay placing the DonorCare over the needle hub until the end of the blood collection. In such situations:
Leave the DonorCare on the tubing behind the needle hub. At the end of the blood collection carefully remove the tape from the needle hub and slide the DonorCare over the hub so that it covers approximately one half to two thirds of the needle hub. Withdraw the needle into the DonorCare as stated in steps 6. through 12. above.
Rx ONLY
DonorCare is manufactured by ITL Corporation, Melbourne, Australia.
TERUMO CORPORATION
44-1, 2-CHOME, HATAGAYA, SHIBUYA-KU,
TOKYO 151-0072, JAPAN
© TERUMO CORPORATION December, 2015
IMUFLEX™ WB-RP
TERUMO
BLOOD BAG SYSTEM WITH INTEGRAL WHOLE BLOOD LEUKOCYTE
REDUCTION FILTER (REMOVING PLATELETS) WITH DIVERSION
BLOOD SAMPLING ARM™
CPD WITH OPTISOL RED CELL PRESERVATIVE SOLUTION
FOR COLLECTION OF 500mL OF BLOOD
Each unit consists of a collection bag containing 70mL of Anticoagulant
CPD solution, with a satellite bag containing 111mL of OPTISOL Red
Cell Preservative Solution.
Each 70mL Anticoagulant CPD solution USP contains 1.79g Dextrose
(monohydrate) USP, 1.84g Sodium Citrate (dihydrate) USP, 209mg Citric
Acid (anhydrous) USP, 156mg Monobasic Sodium Phosphate
(monohydrate) USP.
Each 111mL OPTISOL Red Cell Preservative Solution contains 974mg
Sodium Chloride USP, 1.00g Dextrose (monohydrate) USP, 583mg Mannitol
USP, 33.3mg Adenine USP.
STERILE, NON-PYROGENIC
FLUID PATH.
DO NOT USE UNLESS
ANTICOAGULANT IS CLEAR.
NDC:53877-006-06
CODE
LOT No.
EXPIRY
500 UNITS
DONOR NEEDLE 16G × 1 ½" (1.60 × 38 mm)
Rx ONLY
RECOMMENDED STORAGE : Room Temperature (15-30 °C/ 59-86 °F).
Avoid excessive heat. Protect from freezing.
After opening, unused bags may be stored for 30 days by returning cover film to original
position and sealing with tape to prevent possible loss of moisture.
See Instructions for Use.
Manufactured by : TERUMO CORPORATION Tokyo, Japan
All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION,
its affiliates, or unrelated third parties.
Rev. 2024-01
SC-4-HR6-A2 1
| Class | Version | Type | Effective |
|---|---|---|---|
| ANHYDROUS CITRIC ACID Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| MANNITOL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| SODIUM CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53877-006-01 | IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative | 3 in 1 BLISTER PACK | KIT | 3 | 7 | |
| 53877-006-02 | IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative | 1 in 1 BAG | KIT | 1 | 7 | |
| 53877-006-06 | IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative | 6 in 1 CASE | KIT | 6 | 7 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53877-006 | IMUFLEX WB-RP BLOOD BAG SYSTEM WITH INTEGRAL WHOLE BLOOD LEUKOCYTE REDUCTION FILTER (REMOVING PLATELETS) WITH DIVERSION BLOOD SAMPLING ARM ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND OPTISOL (AS-5) RED CELL PRESERVATIVE (ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND AS-5 RED CELL PRESERVATIVE) KIT [TERUMO CORPORATION] | 7 | Current NDC, Legacy NDC, 3 package rows | 20240830_8b22a4c8-2d6e-45d5-82e2-02ef0b713095.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Adenine | ACTIVE INGREDIENT | JAC85A2161 | 2 | |
| Anhydrous Citric Acid | ACTIVE INGREDIENT | XF417D3PSL | 2 | |
| Dextrose Monohydrate | ACTIVE INGREDIENT | LX22YL083G | 2 | |
| Mannitol | ACTIVE INGREDIENT | 3OWL53L36A | 2 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Sodium Phosphate, Monobasic | ACTIVE INGREDIENT | 3980JIH2SW | 2 | |
| Trisodium Citrate Dihydrate | ACTIVE INGREDIENT | B22547B95K | 2 | |
| Adenine | ACTIVE MOIETY | JAC85A2161 | 2 | |
| Citric Acid | ACTIVE MOIETY | 2968PHW8QP | 2 | |
| Dextrose | ACTIVE MOIETY | IY9XDZ35W2 | 2 | |
| Mannitol | ACTIVE MOIETY | 3OWL53L36A | 2 | |
| Phosphoric Acid | ACTIVE MOIETY | E4GA8884NN | 2 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 53877-006 | 53877-006-02, 53877-006-01, 53877-006-06 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Trisodium Citrate Dihydrate | B22547B95K | ACTIM |
| Sodium Phosphate, Monobasic, Unspecified form | 3980JIH2SW | ACTIB |
| Dextrose Monohydrate | LX22YL083G | ACTIB |
| Water | 059QF0KO0R | IACT |
| Anhydrous Citric Acid | XF417D3PSL | ACTIB |
| Sodium Chloride | 451W47IQ8X | ACTIB |
| Dextrose Monohydrate | LX22YL083G | ACTIB |
| Mannitol | 3OWL53L36A | ACTIB |
| Adenine | JAC85A2161 | ACTIB |
| Water | 059QF0KO0R | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) AND AS-5 RED CELL PRESERVATIVE | Terumo Corporation | 8b22a4c8-2d6e-45d5-82e2-02ef0b713095 | 2024-08-27 | Warnings | 53877-006-01 53877-006-02 53877-006-06 53877-006 53877000606 53877000601 53877000602 481fee63-9b4b-48fa-8e45-8636ec79cbb7 8b22a4c8-2d6e-45d5-82e2-02ef0b713095 |
Adverse event summaries are temporarily unavailable. Other product information remains available.